OTC · Medical - Instruments & Supplies

Ansell Limited (ANSLY) Stock

$84.09 +0.00% OTC: ANSLY Healthcare

Ansell Limited specializes in the creation, development, and production of protective solutions, with its market presence spanning the Asia Pacific region, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. The company is organized into two principal divisions: Healthcare and Industrial.

Valuation

MetricValue
Price$84.09
Market Cap$2.96B
P/E Ratio23.51
P/B Ratio1.65
P/S Ratio1.54
EPS (TTM)$3.58
52-Week High$96.27
52-Week Low$74.38
Dividend Yield2.51%

Financials & Margins

MetricValue
ROE7.05%
ROA4.17%
ROCE8.12%
Gross Margin41.95%
Operating Margin11.24%
Net Margin6.72%
Debt/Equity0.46
Current Ratio2.36

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0B$2.0B$1.7B$1.6B$2.0B
Operating Profit$330.0M$237.0M$199.0M$179.0M$109.0M
Net Profit$247.0M$159.0M$148.0M$77.0M$102.0M
EPS$7.60$4.96$4.68$2.36$2.76
Op Margin16.3%12.1%12.0%11.1%5.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.7B$2.5B$2.5B$3.2B$3.3B
Total Liabilities$1.2B$949.0M$913.0M$1.3B$1.3B
Cash$240.0M$206.0M$159.0M$912.0M$238.0M
Borrowings$516.0M$486.0M$493.0M$857.0M$806.0M

Latest News

Personal Protective Equipment (PPE) Global Market Forecast to 2031 Featuring 3M, Protective Industrial Products, Ansell, DuPont de Nemours, MSA Worldwide and Other Key Players GlobeNewswire · Jul 15, 2026 Personal Protective Equipment Market to Reach USD 34.22 Billion by 2031 | 3M, DuPont, Ansell, MSA, and 37 Key Players Profiled | Arizton PR Newswire · Jun 16, 2026 Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction ACCESS Newswire · May 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$155.0M$192.0M$162.0M$255.0M$239.0M
Investing Cash Flow$-168.0M$-135.0M$-142.0M$-126.0M$-773.0M
Financing Cash Flow$-99.0M$-176.0M$-47.0M$-72.0M$-70.0M
Net Cash Flow$-169.0M$-34.0M$-47.0M$753.0M$-674.0M
Free Cash Flow$72.0M$128.0M$95.0M$192.0M$170.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.27
EV / EBITDA12.22
FCF Yield5.37%
Quick Ratio1.13
Interest Coverage5.01
Return 1Y7.02%
Return 3Y34.77%
Return 5Y-21.23%

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Rhumbline Advisers1,4142026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
GLPGFLakefront Biotherapeutics $28.08 +0.00% 3.47 $1.85B 0.00%
HYPMYHypera S.A. $4.00 -0.93% 7.63 $2.82B 5.00%
MAHLYMediPal Holdings Corporation $17.99 +0.00% 13.62 $3.68B 2.06%
MEPDFMediPal Holdings Corporation $18.35 +0.00% 13.95 $3.76B 2.29%
RGEDFGedeon Richter PLC $37.85 +2.03% 9.35 $6.92B 5.58%

About Ansell Limited

Ansell Limited specializes in the creation, development, and production of protective solutions, with its market presence spanning the Asia Pacific region, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. The company is organized into two principal divisions: Healthcare and Industrial. The Healthcare segment delivers a variety of products, including surgical, single-use, and examination gloves, along with sterile gloves, garments, and other consumables. These essential items are supplied to a broad client base, such as hospitals, surgical centers, dental and veterinary practices, emergency services personnel, research laboratories, and organizations in the life sciences and pharmaceutical sectors. In contrast, the Industrial segment is focused on manufacturing and distributing hand and chemical protective apparel. These solutions are applied in numerous industrial settings, including the automotive industry, chemical processing, metal fabrication, machinery and equipment production, food manufacturing, construction, mining, oil and gas operations, and for first responders. Established in 1893, the company was formerly known as Pacific Dunlop Limited until its rebranding to Ansell Limited in 2002. Its headquarters are located in Richmond, Australia, and P. D. Holdings Pty. Ltd. operates as a current subsidiary.

Ansell Limited is headquartered in AU.

Ansell Limited (ANSLY) stock trades at $84.09 with a market capitalization of $2.96B. The stock is valued at a price-to-earnings (P/E) ratio of 23.51, price-to-book of 1.65, price-to-sales of 1.54. Over the past 52 weeks the stock has ranged between $74.38 and $96.27, and currently trades 12.7% below its 52-week high. It pays a dividend yielding 2.51%.

On profitability, Ansell Limited generates a return on equity (ROE) of 7.05%, return on capital employed of 8.12%, an operating margin of 11.24%, a net profit margin of 6.72%.

Official website: www.ansell.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides